510(k) device
Artemis, Artemis TPO, Artemis MX
Eigen · Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ, Class II) · First FDA decision Oct 12, 2023, newest Oct 12, 2023Liver disease and liver cancerTumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Artemis Artemis TPO"
MAUDE reports
0
Brand "Artemis Artemis TPO", since 2015
PubMed studies
0
Mentioning "Artemis Artemis TPO"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Artemis, Artemis TPO, Artemis MX
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K222222 · Decided Oct 12, 2023 · 444 days after receipt
Device type: Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Psychiatric Diagnostic Evaluation and Psychotherapy ServicesLocal determinationIn effectL33252First Coast Service Options, Inc.Updated Jun 19, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Artemis Artemis TPO", any status and sponsor, newest update first.
No registered device study names "Artemis Artemis TPO".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Artemis Artemis TPO", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QTZ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Artemis Artemis TPO"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QTZ.
- myAblation Guide (VC10A)Siemens Healthcare GmbH · 510(k) 2026
- VisAble.IOTechsomed · 510(k) 2024
- HistoSonics® Planning ToolHistoSonics, Inc. · 510(k) 2026
- BioTraceIO Vision (V1.7)Techsomed Medical Technologies · 510(k) 2025
- Ablation-fitR.a.w. S.r.l · 510(k) 2023
- MIM-AblationMim Software, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.